[ad_1]

New Delhi: The second wave of corona is still permanent and the third wave is also in danger. Against this backdrop, there is some comforting news. The country’s pharmaceutical pricing regulator (NPPA) has decided to bring trade margin on essential medical devices such as pulse oximeter, blood pressure monitor, nebulizers, digital thermometer, glucometer. Accordingly, the distributor’s margin on all these items has been limited to 70 per cent.

The NPPA (national pharmaceutical pricing authority) has given information in this regard on its Twitter handle. The revised price of all these devices will come into effect from July 20. This decision will be effective till July 31, 2022. At present, the margin limit for all the five devices ranges from 3 per cent to 709 per cent.

The second wave created scarcity

The second wave of corona was triggered by a shortage of oxygen. Also, the demand for essential testing equipment had suddenly increased. As a result, they were being sold at high prices in medical stores. The crowds of patients in the hospitals and the lack of health facilities were causing difficulties in the examination of the patients. The result was a shortage of equipment needed for testing. As a result, their prices skyrocketed.

coronavirus india: Karona rules fuzz; Union Home Secretary’s letter to the states

Tax cuts on essential medicines

Last month, the central government reduced taxes on 18 products needed for coronary treatment. These included hand sanitizers, pulse oximeters, test kits, ambulances and thermometers. GST on toxilizumeb and amphotericin B for black fungus required for treatment of corona was reduced from 5 per cent to zero per cent. GST on remediquivir was also reduced from 12 per cent to 5 per cent.

Covid19: 624 victims in one day and more than 37 lakh vaccine use

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here